Food, mapped.
GLP-1 agonists are redrawing the map of appetite.
The Alimentary help food businesses understand what that means for their products, their customers and their plans. Then we help them act on it.
The market is moving. Fast.
GLP-1 medications such as semaglutide and tirzepatide change how people eat. Users feel less hungry, eat smaller portions and
choose food differently; and the number of users is growing fast.
That shift lands on every part of a food business: product development, pack sizes, marketing and policy. Most teams know it matters.
Few have dietitian-led insight to guide what comes next.
The Alimentary was built to close that gap.
Clinical science.
Clear communication.
Ashley Wilson (owner and operator of The Alimentary) is a New Zealand Registered Dietitian who led nutrition communications for FMCG brands, QSR chains and food industry bodies across Australia and New Zealand.
She knows the evidence. She also knows how decisions get made inside a food business.
Registered Dietitian, New Zealand
Cuisine's Most Inspirational Women in Food & Drink Aotearoa 2025
Former Head of FoodGroup, Network Communications
Insight you can act on.
GLP-1 strategy: See how GLP-1 use is changing appetite, portions and category demand. Then turn that insight into product decisions.
Nutrition communications: Clear, evidence-based messaging for brands and campaigns. Backed by science. Written for people.
Food policy advice: Practical input on nutrition policy and FSANZ consultations, from someone who knows both the science and the shelf.
Need a speaker who makes the science land?
Look no further - The Alimentary gives keynotes, panels and workshops on GLP-1s, nutrition science and the future of food. Current, clear and grounded in evidence.
What's changing in your category?
Tell us what you're working on. We'll show you where GLP-1s fit in the picture and what to do next.
Follow Our Latest Insights